ArticleCureus2026
Iatrogenic Thyrotoxicosis and Corticosteroid-Triggered Hypokalemic Periodic Paralysis in a Patient With Treated Hypothyroidism.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypokalemic periodic paralysis (HPP) is a rare disorder characterized by episodic weakness with hypokalemia, most commonly associated with thyrotoxic periodic paralysis (TPP) in the setting of endogenous hyperthyroidism. We present a unique case of a 32-year-old male patient with a history of hypothyroidism who developed recurrent episodes of acute paralysis due to iatrogenic thyrotoxicosis from levothyroxine over-replacement. Notably, each episode occurred shortly after corticosteroid administration, suggesting a dual-trigger mechanism. The patient presented with profound, predominantly proximal bilateral extremity weakness with greater upper limb involvement on formal examination (2/5 proximally, an uncommon distribution in TPP) alongside severe hypokalemia (1.8-1.9 mmol/L). Laboratory evaluation revealed suppressed thyroid-stimulating hormone (TSH), and symptoms resolved rapidly with potassium repletion and supportive care. Discontinuation of levothyroxine resulted in clinical stabilization without recurrence during hospitalization. This case highlights an uncommon etiology of TPP due to exogenous thyroid hormone excess and underscores the role of corticosteroids as a potential precipitating factor. Recognition of this interaction is critical for timely diagnosis, prevention of recurrence, and appropriate management. Clinicians should maintain a high index of suspicion for TPP in patients presenting with acute weakness and hypokalemia, even in the absence of known hyperthyroidism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.